The organic CER growth at -11% is a major negative surprise, and the H1 organic CER growth is 1%.
- Sales -1%, adj. EBIT -2.7m vs. ABGSCe - EBIT lower on higher than expected opex - Recycling contin...
- Q2 sales 8% below our ests. at SEK 202m, for -9% org.
- Q2: Sales 6% above, EBITDA NOK 7m vs ABGSCe NOK 3m - Positive development in projects - Only minor...
Redeye updates its view on Nanologica following the Q2 report.
Incap has guided for net sales to grow by 0-20% for 2025.
- We cut '25e-'27e adj. EBITA by 5-4% - Pressure on demand and hourly prices - NTM EV/EBITA below 7x...
'25e-'27e adj. EBIT down 8-2% Incident in Spain weighs on near-term momentum Trading at NTM EV/EBITA...
- Occupancy improvement in Q2 - Management open for more accretion - 2025e P/CEPS at 14x, ~12.
Prisma Properties, noterat i juni 2024, fokuserar på externa handelsplatser i trafiknära lägen med i...
The company posted a trading statement in late June.
Redeye provides an initial take on Waystream’s Q2 numbers that were presented this morning, which ca...
Redeye comments on Carasent’s Q2 report, showing a more positive outlook than the preliminary figure...
Redeye shares its thoughts and fine-tunes its estimates ahead of CTEK’s Q2 report, which is due Thur...
Redeye publishes a preview of Transtema’s Q2 report.
